Clinical guidelines for acute pancreatitis (AP) recommend cholecystectomy during the index admission of patients with ABP. This recommendation is not consistently followed, and as a result, the risk of recurrence of ABP is increased. Prof. de la Iglesia-Garcia said that his team aimed to develop a model to determine the risk of recurrence of ABP to prioritise patients on surgical waiting lists. The study made use of a multicentre, retrospective cohort study of patients with a first episode of ABP from January 2010 to December 2015 (n=498). Patients were included upon abdominal ultrasound identification of stones or sludge/microlithiasis in the common bile duct or gallbladder (identified on endoscopic ultrasonography or magnetic resonance cholangiography), together with the absence of AP relapse after cholecystectomy. The primary outcome was the risk of ABP recurrence during the 6-month period after the first episode.
Median time to cholecystectomy was 136 days (range 72-206 days). Patients waiting more than 6 months for cholecystectomy were excluded. A total of 352 patients were finally included (mean age 67.6 years, range 51.6 -77.4; 199 female). ABP relapse occurred in 89 patients (25.3%). Serum alkaline phosphatase at admission, previous endoscopic sphincterotomy, and the severity of the first episode of ABP were all significantly associated with ABP recurrence. The investigators developed a score system (recurrence acute biliary pancreatitis -RABP- score, see Table) based on these measures to categorise patients with ABP into low-, intermediate-, or high-risk groups of recurrence. Assigned scores identified patients with ABP who recurred with a c-statistic of 0.59 (95% CI 0.55-0.64; P<0.01). In the future, this score might be applied to prioritise patients in surgical waiting list for cholecystectomy.
Table. RABP scoring system to stratify patients with acute biliary pancreatitis into low (4 to 8 points), intermediate (9 to 11 points), or high-risk groups (12 to 13 points) [1]
- De la Iglesia-Garcia D, et al. UEG Week 2019, Abstract OP304
Posted on
Previous Article
« Locally active corticosteroid promising in eosinophilic oesophagitis Next Article
Faecal microbiota transplantation is effective for irritable bowel syndrome »
« Locally active corticosteroid promising in eosinophilic oesophagitis Next Article
Faecal microbiota transplantation is effective for irritable bowel syndrome »
Table of Contents: UEGW 2019
Featured articles
Interview with UEG President Prof. Paul Fockens
Upper GI Disorders
Locally active corticosteroid promising in eosinophilic oesophagitis
First-in-human radiofrequency vapor ablation in Barrett’s oesophagus
Irritable Bowel Syndrome
Faecal microbiota transplantation is effective for irritable bowel syndrome
Human milk oligosaccharides improve IBS symptoms
Inflammatory Bowel Disease
Ustekinumab is safe and effective in ulcerative colitis: 2-year data
Decreased microvilli length in CD patients
Phase 2 data shows benefit for mirikizumab in CD patients
Subcutaneous ustekinumab as maintenance therapy in UC
First evidence of long-term efficacy of ABX464 in ulcerative colitis
New treatment may reverse coeliac disease
IBD prevalence 3 times higher than estimated and expected to rise
Microbiome and Microbiota
Early stages of gastric metaplasia: molecular profiling
Plant-based foods and Mediterranean diet associated with healthy gut microbiome
Antibiotic resistance in H. pylori has doubled over last 20 years
Pancreatitis
New model predicts recurrence of acute biliary pancreatitis
Hepatology
Restrictive strategy for cholecystectomy selection does not reduce pain, but does reduce surgery
β-blockers may halt cirrhosis progression: PREDESCI trial
Obeticholic acid prevents liver fibrosis from NASH
Oncology
Metal stents are better than plastic for endoscopic biliary drainage
Ramosetron relieves low anterior resection syndrome
Immunonutrition during neoadjuvant oesophagogastric cancer therapy: no benefit
Endoscopy
EUS-guided histological specimens from the pancreatic cyst wall
Digital single-operator cholangioscopy more sensitive than endoscopic retrograde cholangiopancreatography
New single-use duodenoscope well-liked by endoscopists
Related Articles
October 23, 2019
Ileal microbiota predict recurrence in CD patients after resection
October 23, 2019
First evidence of long-term efficacy of ABX464 in ulcerative colitis
October 23, 2019
Early stages of gastric metaplasia: molecular profiling
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com